Dr. Steve Kay, in collaboration with Dr. Seva Katritch, was awarded a new grant “Targeting circadian clock proteins for novel therapeutics to treat Acute Myeloid Leukemia” from the Ming Hsieh Institute (MHI) for Research on Engineering Medicine for Cancer.
top of page
bottom of page